Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eldecalcitol vs Alfacalcidol in Osteoporosis
NCT00144456Phase 3Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Sep 2004
- Primary completion
- Sep 2008
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial of eldecalcitol in osteoporosis (2 arms), sponsored by Chugai Pharmaceutical Co., Ltd. Primary endpoint: Incidences of vertebral fracture at 144 weeks. Started Sep 2004; status: completed.
02
Drugs
eldecalcitol
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00144456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00144456.